Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cardio Safety: Does FDA Expect More From Obesity Than Diabetes Products?

13 Jun 2011

Related Content

Obesity Drugs Go Back To The Drawing Board; FDA To Hold Advisory Cmte On CV Risk

03 Jun 2011

FDA Diabetes Guidance Encourages Enrollment Of Sicker Patients

17 Dec 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.